CD276 and prostate cancer: Fractionated irradiation also upregulates expression of the immune checkpoint B7-H3 (CD276) on prostate cancer stem cells, and B7-H3 CAR T cells have demonstrated a potent cytotoxicity in vitro and significantly improved antitumor efficacy in mice [52].